cro.directory
← Compare landing

Creative Bioarray vs ITR Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/creative-bioarray/itrlab

CategoryCreative BioarrayITR Laboratories
Listed sitecrocro
SummaryCreative Bioarray provides preclinical research solutions including drug screening, ADME-PK, toxicity studies, and cell-based services across oncology, neurology, cardiovascular, and metabolic therapeutic areas.GLP-compliant nonclinical CRO specializing in safety and toxicology testing across in silico, in vitro, and in vivo modalities, with 35+ years of experience and nearly 6,000 completed studies.
Services
  • In Vitro ADME / DMPK
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Safety Pharmacology
  • High-Throughput Screening
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • Translational Research
  • Specialized & Large-Animal Models
  • GLP Toxicology
  • Safety Pharmacology
  • Genetic Toxicology
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • In Vivo PK / PD Studies
  • Preclinical In Vivo Studies
  • Pathology & Histology Services
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Peptide
  • Oligonucleotide
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Small Molecule
  • Biologics (Other)
Indications
  • Oncology
  • Neurology
  • Cardiovascular
  • Metabolic
Data not yet provided.
LocationsData not yet provided.
  • Headquarters, Baie-D'Urfe, Quebec, Canada
  • US Office, Cambridge, Massachusetts, USA
Certifications
  • ISO · Identifier: ISO 13485
  • ISO · Identifier: ISO 9001
  • AAALAC · Identifier: AAALAC accredited
  • CCAC · Identifier: CCAC accredited
  • FDA · Identifier: FDA inspected
  • EMA · Identifier: EMA inspected
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.